Vytrus Biotech SA
MAD:VYT

Watchlist Manager
Vytrus Biotech SA Logo
Vytrus Biotech SA
MAD:VYT
Watchlist
Price: 11.8 EUR
Market Cap: €90.2m

Wall Street
Price Targets

VYT Price Targets Summary
Vytrus Biotech SA

There are no price targets for VYT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Vytrus Biotech SA Competitors:
Price Targets
FMBH
First Mid Bancshares Inc
12% Upside
AOF
Atoss Software AG
63% Upside

Revenue
Forecast

33% / Year
Past Growth
32% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
33% / Year
Past Growth
32% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 5 years the compound annual growth rate for Vytrus Biotech SA's revenue is 33%. The projected CAGR for the next 4 years is 32%.

Operating Income
Forecast

N/A
Past Growth
60% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
60% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Vytrus Biotech SA's operating income for the next 4 years is 60%.

Net Income
Forecast

N/A
Past Growth
52% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
52% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of Vytrus Biotech SA's net income for the next 4 years is 52%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VYT's stock price target?
Not Available

VYT doesn't have any price targets made by Wall Street professionals.

What is Vytrus Biotech SA's Revenue forecast?
Projected CAGR
32%

For the last 5 years the compound annual growth rate for Vytrus Biotech SA's revenue is 33%. The projected CAGR for the next 4 years is 32%.

What is Vytrus Biotech SA's Operating Income forecast?
Projected CAGR
60%

The compound annual growth rate of Vytrus Biotech SA's operating income for the next 4 years is 60%.

What is Vytrus Biotech SA's Net Income forecast?
Projected CAGR
52%

The compound annual growth rate of Vytrus Biotech SA's net income for the next 4 years is 52%.

Back to Top